Please assess the completion status of the following clinical trial:

Trial Title: A Multiple Dose Study to Assess the Safety and Tolerability of BMS-963272 in Obese But Otherwise Healthy Adults

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 3.0

Eligibility Criteria:
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com~Inclusion Criteria:~* Participants must be in good general health, in the opinion of the investigator, with no clinically significant deviation from normal in medical history, physical examination findings, ECGs, or laboratory results.~* Participants must have a BMI of 30 kg/m2 to 40 kg/m2 inclusive~* Women (not of childbearing potential) and men aged 18 to 60 years, inclusive~Exclusion Criteria:~* Previous participation in the current study~* Inability or unwillingness to comply with protocol-defined restrictions or requirements regarding lifestyle, diet, concomitant medications, or other aspects of the study~* Inability to tolerate the oLTT meal or to comply with oLTT testing conditions~* Inability to tolerate oral medication~* Inability to tolerate venipuncture and/or inadequate venous access~* Women who are breastfeeding~* Medical Conditions~* History of lactose intolerance~* Any significant (in the opinion of the investigator) acute or chronic illness~* Type 1 or 2 diabetes~* Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECG, or clinical laboratory determinations beyond what is consistent with the target population~* Previous/Concomitant Therapy~* Previous exposure to BMS-963272~Other protocol-defined inclusion/exclusion criteria could apply

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 60 Years
- Healthy Volunteers: t

Study Arms:
- BMS-963272 or Placebo once daily (QD) (Type: EXPERIMENTAL): None
- BMS-963272 or Placebo every 12 hours (Q12H) (Type: EXPERIMENTAL): None
- BMS-963272 or Placebo every 8 hours (Q8H) (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).